Oct. 1 at 10:25 PM
$CRVO Don’t forget: FTD study (in France) phase 2a should conclude in March, results April - according to http://clinicaltrials.gov. Ischemic stroke (in Australia) concludes May, results June. 3Q2026 initiation of DLB phase 3.
It’s been a little while since I looked, so I could be misremembering by a bit, but the main points should be correct. Except for the fundraising to finance phase 3, we should see a lot more catalytic PRs in a few months than we have seen in years. Catalyst after catalyst after catalyst. I like their plan.
